UCSF First in State to Provide FDA-Approved CAR-T for Pediatric Cancer Patients – UCSF News Services
Winchester Herald Chronicle |
UCSF First in State to Provide FDA-Approved CAR–T for Pediatric Cancer Patients
UCSF News Services CAR-T represents a radically different way of treating cancer. It entails filtering T–cells from the patient’s blood and reprogramming them to harbor a “chimeric antigen receptor,” or CAR, that zeroes in on cancer and develops millions of copies of the … Monroe Carell Jr. Children’s Hospital at Vanderbilt to offer new cutting-edge treatment for type of pediatric leukemiaWinchester Herald Chronicle |
|
Man beats cancer with immunotherapy and cycling
New Haven Register (AP) — Doctors told South Meriden resident Daniel Santomero he had 18 months to live in August 2015 when he was diagnosed with Stage-4 head and neck cancer. Two years later, he has beaten the odds thanks to experimental immunotherapy treatment. |
|
Man beats cancer with immunotherapy and cycling
CT Post (AP) — Doctors told South Meriden resident Daniel Santomero he had 18 months to live in August 2015 when he was diagnosed with Stage-4 head and neck cancer. Two years later, he has beaten the odds thanks to experimental immunotherapy treatment. |
OncLive |
NSCLC Immunotherapy: Transformation of Upfront Therapy
OncLive Everett Vokes, MD: Hello, and thank you for joining this OncLive® Peer Exchange® titled “Immuno-Oncology in Advanced Lung Cancer.” We continue to see extraordinary progress in the treatment of advanced non–small cell lung cancer, with … |